The Winter AAJ conference provided terrific insight into the status of a number of high profile litigations. Risperdal cases involving patients suffering gynecomastia proved successful after a Philadelphia jury awarded a plaintiff $2.5 million in the first trial involving that product. Emerging litigation involving Xarelto and Zofran find themselves well positioned to be successful in redressing the injuries suffered by patients with internal bleeding and birth defects respectively. Fosamax Femur cases have renewed life given a current trial in Santa Ana that will be closely watched. Trans Vaginal Mesh cases continue to succeed as do Actos cases especially in state court where juries continue to find in favor of compensation. Morris Law Firm is currently engaged in business litigation involving Ponzi schemes enabled by improper banking practices as well as pharmaceutical and mesothelioma trials.